医学
肾损伤
糖脂
疾病
肾
糖尿病
新陈代谢
肾脏疾病
生物信息学
药理学
内科学
内分泌学
生物
免疫学
作者
Anqi Feng,Ruili Yin,Rong Xu,Baoyu Zhang,Longyan Yang
标识
DOI:10.3389/fphar.2025.1559026
摘要
Diabetic kidney disease (DKD) is a severe microvascular complication of diabetes, which can result in end-stage renal disease (ESRD). As the main site of renal reabsorption and its exposed environment, renal tubules can be damaged by various factors. Recent studies have shown that renal tubular epithelial cells (RTECs) injury plays an important role in the occurrence and progression of DKD. The glycolipid metabolism disorders are a vital factor contributing to RTECs injury, which in turn affects the progression of DKD. Abnormal glucose and lipid metabolism can cause oxidative stress, mitochondrial damage, cell apoptosis and lipid accumulation, which can cause RTECs injury. Therefore, this review describes the main pathological mechanism of the injury caused by glycolipid metabolism and the corresponding therapeutic drugs in the clinical treatment of DKD.
科研通智能强力驱动
Strongly Powered by AbleSci AI